))
Thyroid Eye Disease: Conversations on Comprehensive Comanagement: Treatment (CE/CME Podcast) - Part 2
Manage episode 471102622 series 3453910
Content provided by MedEdicus. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by MedEdicus or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.
This podcast, Part 2 of a 3-part series on thyroid eye disease (TED), provides an in-depth discussion of treatment strategies, focusing on current medical and surgical options as well as emerging therapies. Faculty review clinical data on teprotumumab, the only FDA-approved agent for TED. Listeners will also be introduced to clinical data on treatments including glucocorticoids, orbital radiation, rituximab, and tocilizumab and learn how to select appropriate therapies across a spectrum of disease activity and duration.
13 episodes
Share
